STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #489 by analyst upside · 2026-06-27
OABI
OmniAb, Inc.
Healthcare · Market Cap $365M · P/E 0x
ANALYST PRICE TARGET
+191.0%
implied upside to consensus target
Current Price $2.52
Consensus Target $7.33
Bull Target $11.0
Bear Target $3.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
6
Hold
0
Sell
0
52-Week Low $1.3
52-Week High $2.79
YTD Return +34.0%
FUNDAMENTALS
Market Cap $365M
P/E Ratio (TTM) N/A
Forward P/E -7.8x
EPS (TTM) $-0.46
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $29M
Profit Margin -187.6%
52-WEEK RANGE
52-Week Low $1.3
52-Week High $2.79
Current Price $2.52
Bear Target $3.0
Bull Target $11.0
● Now $2.52 ● Target $7.33
TRADING DATA
Avg Volume 695K
YTD Return +34.0%
Analyst Count 6
Consensus Buy
Upside to Target +191.0%
Last Updated 2026-06-27

ANALYST SUMMARY

OmniAb, Inc. (OABI) is currently trading at $2.52 with a Wall Street consensus price target of $7.33, implying potential upside of 191.0% over the next 12 months. 6 analysts currently cover OABI, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $11.0, while the most cautious has a target of $3.0.

OABI operates in the Healthcare sector with a market capitalisation of $365M. The stock is up 34.0% year-to-date and is currently trading near the upper end of its 52-week range of $1.3 – $2.79.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OABI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital — Reiterated
Outperform → Outperform 2025-08-07 Building track record
Benchmark reit
Buy → Buy 2025-05-12 Building track record
RBC Capital — Reiterated
Outperform → Outperform 2025-03-27 Building track record
Benchmark — Reiterated
Buy → Buy 2025-03-20 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-03-19 31% win rate (48 calls)
Benchmark reit
Buy → Buy 2024-11-14 Building track record
HC Wainwright & Co. reit
Buy → Buy 2024-11-14 31% win rate (48 calls)
Benchmark reit
Buy → Buy 2024-08-19 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
15/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →